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Is the Gulf War Syndrome (GWS) and the silicone
related scleroderma –like syndrome spectres of the
same disease? What do they have in common with
a rare aluminium induced myopathic syndrome
described for the first time in France in 1998? The
logic answer was suggested by an elegant integra-
tion of the existing evidence into the autoim-
mune/inflammatory syndrome induced by adju-
vants (ASIA) proposed recently by Shoenfeld in a
paper published in Journal of Autoimmunity1. A
mosaic of environmental factors can be classified
as adjuvants. In fact, we know for decades a variety
of compounds that are able to induce autoimmu-
nity in animal models and used in clinical practice
to increase the immunogenicity of vaccines, but
also known to be able, in genetic susceptible indi-
viduals, to induce autoimmune diseases2,3. In this
vast group of substances bacterial antigens, hor-
mones, aluminium, silicone and several other
molecules have been included4.
The GWS was described in veterans that were suf-
fering from atypical rheumatic symptoms, such as
arthralgia, myalgia, lymphadenopaty, chronic fatigue
syndrome, malar rash and autoimmune thyroiditis5.
A cohort study performed 10 years ago com-
pared the titter of anti squalene antibodies of 144
Golf War immunized veterans or medical emplo -
yees, 48 blood donors, 40 systemic lupus erythe-
matosus patients, 34 silicone breast implant reci -
pients and 30 chronic fatigue syndrome patients.
The majority (95%) of overtly ill deployed GWS pa-
tients had antibodies to squalene. All (100%) GWS
patients immunized for service in Desert Shield/
/Desert Storm who were not in the fighting front
had antibodies to squalen. In contrast, none (0%)
of the veterans that were in the fighting zone and
were not showing signs and symptoms of GWS have
antibodies to squalen. Neither patients with idio-
pathic autoimmune disease nor healthy controls
had detectable serum antibodies to squalene. The
majority of symptomatic GWS patients had serum
antibodies to squalene6.The authors proposed that
GWS was not a result of the exposition to weapons
but rather induced by the intense vaccination pro-
gram that they were submitted to. It is ironic that
more solders were ill due to an oil adjuvant injec -
ted in their organisms than fighting against the hos-
tile environment and the armed enemies.
Silicon was considered an inert material and
thus unable to induce immune reactions. Recent
metanalysis have supported this view, as the risk of
silicon exposed individuals for developing a diffuse
connective tissue disease is only 0.8%, not signifi-
cantly higher than the risk of the general popula-
tion. However, that is not the case for more unspe-
cific symptoms such as arthralgia and myalgia and
even some diffuse neurologic manifestations that
appear to be more common in individuals exposed
to silicon implants7. The possible association be-
tween chronic fatigue syndrome, fibromyalgia, and
previous silicone mammoplasty was proposed al-
most two decades ago8.
The post vaccination muscle disease described
by Gehardi et al. in 1987 is of particular interest as
it is based in well defined histologic features9. It is
a miofasceitis that has the presence of macro pha -
ges with aluminum inclusions, which occurs asso-
ciated with vaccination. Clinically the disease is ex-
pressed by systemic symptoms such as fatigue,
myalgia, arthalgia, fever and, in some cases, by a de-
myelinating condition similar to Guillain-Barré,
with electromyographic changes. Elevated acute
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phase proteins and creatine quinase also occur.
The same group determined that the disease oc-
curs only in HLA DRB1*01 positive individuals9.
On top of that, it was shown that aluminum can
persist in the local of injection, up to 10 years after
vaccine administration, which can explain the per-
sistence of this condition in some individuals10.
These conditions and other observations, re-
garding for instance de H1N1 vaccination, have
motivated the definition of the ASIA syndrome,
with the criteria proposed by Shoenfeld listed in
Table I1. These criteria, if properly validated, are of
great clinical relevance, as they raise a major cli -
nical doubt on the classification of some patients
with chronic pain syndromes, as chronic fatigue
syndrome, or even fibromyalgia. In fact, if we com-
pare the cardinal symptoms of the Shoenfeld’s ASIA
syndrome with the typical clinical manifestations
of patients with diffuse chronic pain we came
quickly to the conclusion that reviewing the recent
exposition to adjuvants and other potential exo -
genous stimulus seems to be a wise attitude. This
is also in line with the characteristic symptoms of
fibromyalgia and chronic fatigue syndrome that
frequently occur in patients with well-defined
Lyme disease, even after adequate treatment. Lyme
disease is caused by an infection due to Borrelia
burgdorferi spirochete and most of the clinical
symptoms are in fact a consequence of an immune
response to this infectious agent. Although a bio-
logical relationship between Lyme disease and dif-
fuse pain syndromes has not been established, in
fact this can be encompassed by the ASIA syn-
drome11. In addition, recent studies have detected
the presence of retroviral sequences like xenotro -
pic murine leukemia virus-related virus (XMRV)
and polytropic murine leukemia virus related-
-virus (PMLV) in chronic fatigue syndrome pa-
tients, expanding, in fact, the need for thinking on
alternative diagnosis in patients classified into
these conditions12. Consequently, countries such as
Australia, Canada, New Zealand and the UK elabo -
rated restrictive guidelines for “blood donors with
a history of current diagnosis of CFS”. If upcoming
research will confirm these observations and vali-
date the ASIA/Shoenfeld criteria, a major paradigm
shift will have to occur in the way rheumatologists
perceive some cases of diffuse chronic pain. Inte -
restingly, in this issue of Acta Reumatologica Por-
tuguesa 2 case reports related to the ASIA/Shoen-
feld are reported13,14.
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Table I. Criteria suggested by Shoenfeld for ASIA diagnosis 
Major Criteria
• Exposure to an external stimuli (infection, vaccine, silicone, adjuvant) prior to clinical manifestations
• The appearance of ’typical’ clinical manifestations:
Myalgia, myositis or muscle weakness
Arthralgia and/or arthritis
Chronic fatigue, un-refreshing sleep or sleep disturbances
Neurological manifestations (especially associated with demyelination)
Cognitive impairment, memory loss
Pyrexia, dry mouth
• Removal of inciting agent induces improvement 
• Typical biopsy of involved organs 
Minor Criteria
• The appearance of autoantibodies or antibodies directed at the suspected adjuvant 
• Other clinical manifestations (i.e. irritable bowel syndrome) 
• Specific HLA (i.e. HLA DRB1, HLA DQB1) 
• Evolvement of an autoimmune disease
For ASIA’s diagnosis: at least 2 major criteria or 2 minor and 1 major.
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